The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination, monitoring treatment reaction and early diagnostics.
2nd Annual MarketsandMarkets Liquid Biopsy/Digital Pathology Conference will unite the pioneers from Diagnostics organization, Experts from Pharmaceutical and Bio-Pharma companies, Researchers and professors from renowned universities to address the challenges in early detection of tumor cells and the potential of liquid biopsies to screen, monitor and treatment of the diseases.
Hospitals- Diagnostics Department, Department of clinical oncology, Pathology Labs
Designation- Oncologist, Immunologist, Hematologist, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors
Universities: Designation- Professors, Researchers, Associate professors in Cancer study
Pharma/Therapeutics: Designation- CEO, COO, Senior scientist in cancer and immunology, Research scientist in cancer, Personalized medicine individuals